cached image

John E. Greenlee, MD - Publications

Affiliations: 
Neurology University of Utah, Salt Lake City, UT 
Website:
http://neuroscience.med.utah.edu/Faculty/Greenlee.html

54 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Greenlee JE, Brashear HR. The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease. Cerebellum (London, England). PMID 35881322 DOI: 10.1007/s12311-022-01446-9  0.407
2022 Greenlee JE, Carlson NG, Abbatemarco JR, Herdlevær I, Clardy SL, Vedeler CA. Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis. Frontiers in Neurology. 12: 744653. PMID 35111121 DOI: 10.3389/fneur.2021.744653  0.396
2022 Greenlee JE, Carlson NG, Abbatemarco JR, Herdlevær I, Clardy SL, Vedeler CA. Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis Frontiers in Neurology. 12. DOI: 10.3389/fneur.2021.744653  0.396
2020 Jaffe SL, Carlson NG, Peterson LK, Greenlee JE. Treatment responsive primary autoimmune cerebellar ataxia in a patient with IgG and IgM anticerebellar antibodies. European Journal of Neurology. PMID 33253468 DOI: 10.1111/ene.14659  0.367
2020 Greenlee JE, Carlson NG. CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration. Annals of Neurology. PMID 32445212 DOI: 10.1002/Ana.25790  0.384
2020 Galli J, Greenlee J. Paraneoplastic Diseases of the Central Nervous System. F1000research. 9: 167. PMID 32194943 DOI: 10.12688/F1000Research.21309.1  0.501
2018 Galli JR, Austin SD, Greenlee JE, Clardy SL. Stiff Person Syndrome with Anti-GAD65 Antibodies Within the National Veterans Affairs Health Administration. Muscle & Nerve. PMID 30192027 DOI: 10.1002/Mus.26338  0.321
2018 Williams JP, Carlson NG, Greenlee JE. Antibodies in Autoimmune Human Neurological Disease: Pathogenesis and Immunopathology. Seminars in Neurology. 38: 267-277. PMID 30011408 DOI: 10.1055/S-0038-1660501  0.469
2016 McKasson M, Clardy SL, Clawson SA, Hill KE, Wood B, Carlson N, Bromberg M, Greenlee JE. Voltage-gated calcium channel autoimmune cerebellar degeneration: Case and study of cytotoxicity. Neurology® Neuroimmunology & Neuroinflammation. 3: e222. PMID 27088118 DOI: 10.1212/Nxi.0000000000000222  0.452
2015 Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Carlson NG. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers. Plos One. 10: e0123446. PMID 25885452 DOI: 10.1371/Journal.Pone.0123446  0.658
2014 Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Jaskowski TD, Carlson NG. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures. Journal of Neuroinflammation. 11: 160. PMID 25228406 DOI: 10.1186/S12974-014-0160-0  0.641
2014 Greenlee JE. The equine encephalitides. Handbook of Clinical Neurology. 123: 417-32. PMID 25015497 DOI: 10.1016/B978-0-444-53488-0.00019-5  0.308
2014 Greenlee JE. Anti-Yo antibody, associated with paraneoplastic cerebellar degeneration, specifically produces Purkinje cell death by binding to the 62 kDa intracellular Yo antigen Journal of Neuroimmunology. 275: 36-37. DOI: 10.1016/J.Jneuroim.2014.08.099  0.475
2013 Greenlee JE. Treatment of paraneoplastic cerebellar degeneration. Current Treatment Options in Neurology. 15: 185-200. PMID 23315179 DOI: 10.1007/S11940-012-0215-4  0.376
2013 Greenlee JE, Clawson SA, Wood B, Hill KE, Carlson NG. Comparative neuronal uptake and cytotoxicity of anti-Hu and anti-Ri antibodies in rat cerebellar and hippocampal slice cultures Journal of the Neurological Sciences. 333. DOI: 10.1016/J.Jns.2013.07.2239  0.465
2010 Greenlee JE. Treatment of paraneoplastic neurologic disorders. Current Treatment Options in Neurology. 12: 212-30. PMID 20842583 DOI: 10.1007/S11940-010-0066-9  0.336
2010 Greenlee JE, Clawson SA, Hill KE, Wood BL, Tsunoda I, Carlson NG. Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures. Journal of Neuropathology and Experimental Neurology. 69: 997-1007. PMID 20838245 DOI: 10.1097/Nen.0B013E3181F0C82B  0.653
2010 Greenlee JE, Clawson SA, Hill KE, Dechet CB, Carlson NG. Antineuronal autoantibodies in paraneoplastic cerebellar degeneration associated with adenocarcinoma of the prostate. Journal of the Neurological Sciences. 291: 74-8. PMID 20089262 DOI: 10.1016/J.Jns.2009.12.019  0.326
2009 Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE. Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. Journal of Neuroinflammation. 6: 31. PMID 19874605 DOI: 10.1186/1742-2094-6-31  0.466
2008 Berger JR, Weaver A, Greenlee J, Wahlen GE. Neurologic consequences of autoimmune polyglandular syndrome type 1. Neurology. 70: 2248-51. PMID 18519874 DOI: 10.1212/01.Wnl.0000313837.45525.B6  0.336
2006 Greenlee JE. Anti-Hu antibody and refractory nonconvulsive status epilepticus. Journal of the Neurological Sciences. 246: 1-3. PMID 16643950 DOI: 10.1016/J.Jns.2006.03.001  0.429
2004 Greenlee JE. Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1090. PMID 15258205 DOI: 10.1136/Jnnp.2004.038489  0.431
2003 O'Neill FJ, Greenlee JE, Dörries K, Clawson SA, Carney H. Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus. Journal of Neurovirology. 9: 567-76. PMID 13129771 DOI: 10.1080/13550280390241223  0.35
2003 O'Neill FJ, Greenlee JE, Carney H. The archetype enhancer of simian virus 40 DNA is duplicated during virus growth in human cells and rhesus monkey kidney cells but not in green monkey kidney cells. Virology. 310: 173-82. PMID 12788641 DOI: 10.1016/S0042-6822(03)00116-8  0.34
2002 Greenlee JE, Steffens JD, Clawson SA, Hill K, Dalmau J. Anti-Hu antibodies in Merkel cell carcinoma. Annals of Neurology. 52: 111-5. PMID 12112058 DOI: 10.1002/Ana.10225  0.475
2001 Greenlee JE, Boyden JW, Pingree M, Brashear HR, Clawson SA, Keeney PM. Antibody types and IgG subclasses in paraneoplastic neurological syndromes. Journal of the Neurological Sciences. 184: 131-7. PMID 11239946 DOI: 10.1016/S0022-510X(01)00442-7  0.474
2000 Greenlee JE, Rose JW. Controversies in neurological infectious diseases. Seminars in Neurology. 20: 375-86. PMID 11051301 DOI: 10.1055/S-2000-9429  0.312
1999 Greenlee JE, Dalmau J, Lyons T, Clawson S, Smith RH, Pirch HR. Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal. Annals of Neurology. 45: 805-9. PMID 10360776 DOI: 10.1002/1531-8249(199906)45:6<805::Aid-Ana18>3.0.Co;2-G  0.479
1998 Greenlee JE. Progressive multifocal leukoencephalopathy--progress made and lessons relearned. The New England Journal of Medicine. 338: 1378-80. PMID 9571261 DOI: 10.1056/Nejm199805073381910  0.336
1995 Gahring LC, Twyman RE, Greenlee JE, Rogers SW. Autoantibodies to neuronal glutamate receptors in patients with paraneoplastic neurodegenerative syndrome enhance receptor activation. Molecular Medicine (Cambridge, Mass.). 1: 245-53. PMID 8529103 DOI: 10.1007/Bf03401549  0.339
1995 Greenlee JE, Burns JB, Rose JW, Jaeckle KA, Clawson S. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathologica. 89: 341-5. PMID 7610765 DOI: 10.1007/Bf00309627  0.451
1995 Moll JW, Antoine JC, Brashear HR, Delattre J, Drlicek M, Dropcho EJ, Giometto B, Graus F, Greenlee J, Honnorat J. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, The Netherlands. Neurology. 45: 1937-41. PMID 7478000 DOI: 10.1212/Wnl.45.10.1937  0.489
1994 Greenlee JE, Clawson SH, Phelps RC, Stroop WG. Distribution of K-papovavirus in infected newborn mice. Journal of Comparative Pathology. 111: 259-68. PMID 7836567 DOI: 10.1016/S0021-9975(05)80004-0  0.364
1993 Sakai K, Ogasawara T, Hirose G, Jaeckle KA, Greenlee JE. Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins. Annals of Neurology. 33: 373-80. PMID 8489208 DOI: 10.1002/Ana.410330407  0.462
1993 Greenlee JE, Parks TN, Jaeckle KA. Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro. Neurology. 43: 2049-54. PMID 8413965 DOI: 10.1212/Wnl.43.10.2049  0.472
1993 Greenlee JE, Burns JB, Rose JW, Jaeckle KA. Systemically Administered Type I (“Anti-Yo”) Igg, Associated With Paraneoplastic Cerebellar Degeneration, Is Taken Up By Rat Cerebellar Purkinje Cells In Vivo Journal of Neuropathology and Experimental Neurology. 52: 321. DOI: 10.1097/00005072-199305000-00245  0.339
1992 Greenlee JE, Brashear HR, Jaeckle KA, Geleris A, Jordan K. Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up. The Western Journal of Medicine. 156: 199-202. PMID 1536083  0.303
1991 Greenlee JE, Phelps RC, Stroop WG. The major site of murine K papovavirus persistence and reactivation is the renal tubular epithelium. Microbial Pathogenesis. 11: 237-47. PMID 1813776 DOI: 10.1016/0882-4010(91)90028-9  0.377
1989 Brashear HR, Greenlee JE, Jaeckle KA, Rose JW. Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms. Neurology. 39: 1605-9. PMID 2685657 DOI: 10.1212/Wnl.39.12.1605  0.492
1988 Greenlee JE, Brashear HR, Herndon RM. Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia. Journal of Neuropathology and Experimental Neurology. 47: 561-71. PMID 3049946  0.384
1987 Greenlee JE, Dodd WK. Serial passage of murine K-papovavirus in primary cultures of mouse embryo cells. Brief report. Archives of Virology. 94: 169-73. PMID 3579608 DOI: 10.1007/Bf01313736  0.347
1986 Greenlee JE. Chronic infection of nude mice by murine K papovavirus. The Journal of General Virology. 67: 1109-14. PMID 3711864 DOI: 10.1099/0022-1317-67-6-1109  0.359
1986 Greenlee JE, Keeney PM. Immunoenzymatic labelling of JC papovavirus T antigen in brains of patients with progressive multifocal leukoencephalopathy. Acta Neuropathologica. 71: 150-3. PMID 3022533 DOI: 10.1007/Bf00687977  0.399
1986 Greenlee JE, Lipton HL. Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration. Annals of Neurology. 19: 82-5. PMID 3004320 DOI: 10.1002/Ana.410190117  0.468
1985 Greenlee JE, Law MF. Interaction of K papovavirus with hamster cells: transformation of glial cells in vitro but failure of the virus to produce central nervous system tumors in vivo. Archives of Virology. 83: 207-15. PMID 3970676 DOI: 10.1007/Bf01309917  0.37
1985 Greenlee JE, Sun M. Immunofluorescent labeling of nonhuman cerebellar tissue with sera from patients with systemic cancer and paraneoplastic cerebellar degeneration. Acta Neuropathologica. 67: 226-9. PMID 3931402 DOI: 10.1007/Bf00687805  0.428
1984 Greenlee JE, Law MF. Persistent infection and transformation of mouse glial cultures by K virus, a murine papovavirus. The Journal of General Virology. 65: 1253-8. PMID 6747603 DOI: 10.1099/0022-1317-65-7-1253  0.38
1984 Greenlee JE, Dodd WK. Reactivation of persistent papovavirus K infection in immunosuppressed mice. Journal of Virology. 51: 425-9. PMID 6379207 DOI: 10.1128/Jvi.51.2.425-429.1984  0.359
1983 Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Annals of Neurology. 14: 609-13. PMID 6360029 DOI: 10.1002/Ana.410140603  0.423
1982 Greenlee JE, Keeney PM. Immunofluorescent labelling of K-papovavirus antigens in glycol methacrylate embedded material: a method for studying infected cell populations by fluorescence microscopy and histological staining of adjacent sections. Stain Technology. 57: 197-205. PMID 6183793 DOI: 10.3109/10520298209066709  0.349
1981 Greenlee JE. Effect of host age on experimental K virus infection in mice. Infection and Immunity. 33: 297-303. PMID 7263066 DOI: 10.1128/Iai.33.1.297-303.1981  0.341
1979 Greenlee JE. Pathogenesis of K virus infection in newborn mice. Infection and Immunity. 26: 705-13. PMID 397932 DOI: 10.1128/Iai.26.2.705-713.1979  0.349
1978 Greenlee JE, Narayan O, Johnson RT. Effects of BK virus infection on primary cultures of rodent and primate cells. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 158: 437-41. PMID 210466 DOI: 10.3181/00379727-158-40220  0.367
1978 Greenlee JE, Becker LE, Narayan O, Johnson RT. Failure to demonstrate papovavirus tumor antigen in human cerebral neoplasms. Annals of Neurology. 3: 479-81. PMID 209724 DOI: 10.1002/Ana.410030604  0.341
Show low-probability matches.